A special session of the General Assembly took place in April revealing a growing divergence in the global drug policy landscape. Difficult negotiations resulted in a disappointing outcome document, perpetuating a siloed approach to drugs at the UN level. There is a clear need to realign international drug policies with the overarching 2030 Agenda and the Sustainable Development Goals, embedding the drugs issue comprehensively within the UN’s three pillars: development, human rights, and peace and security. The UNGASS process has helped to set the stage for more substantial changes in the near future, towards the next UN review in 2019.
The drugs scene in Colombia is characterized by the fact that it is dominated by a confusion of insufficiently supported statistics and speculative diagnoses which produce policies that reflect this chaos.
The 2008 UN World Drug Report tries to hide the failures of drug control policy behind a bad history lesson. Instead of a clear acknowledgement that the UN’s own 10-year targets have not been met, it offers a narrative of 100 years of success, fabricating a comparison with Chinese opium production and use at the turn of the 20th century.
In its 2006 World Drug Report, the UN Office on Drugs and Crime (UNODC) struggles to construct success stories to convince the world that the global drug control regime has been an effective instrument. An escape-route used in this year's World Drug Report is to fabricate comparisons with higher opium production levels a century ago and with higher prevalence figures for tobacco.
In this briefing the Transnational Institute (TNI) analyses the proceedings and results of the CND meeting in Vienna, 7-11 March 2005, outlines several options for follow-up and recommends next steps to take.